Fostering Responsible Innovation in Health: An Evidence-Informed Assessment Tool for Innovation Stakeholders

Background: Responsible innovation in health (RIH) emphasizes the importance of developing technologies that are responsive to system-level challenges and support equitable and sustainable healthcare. To help decision-makers identify whether an innovation fulfills RIH requirements, we developed and validated an evidence-informed assessment tool comprised of 4 inclusion and exclusion criteria, 9 assessment attributes and a scoring system. Methods: We conducted an inter-rater reliability assessment to establish the extent to which 2 raters agree when applying the RIH Tool to a diversified sample of health innovations (n = 25). Following the Tool's 3-step process, sources of information were collected and cross-checked to ensure their clarity and relevance. Ratings were reported independently in a spreadsheet to generate the study's database. To measure inter-rater reliability, we used: a non-adjusted index (percent agreement), a chance-adjusted index (Gwet's AC) and the Pearson's correlation coefficient. Results of the Tool's application to the whole sample of innovations are summarized through descriptive statistics. Results: Our findings show complete agreement for the screening criteria, almost perfect agreement for 7 assessment attributes, substantial agreement for 2 attributes and almost perfect agreement for the RIH overall score. A large portion of the sample obtained high scores for 6 attributes (health relevance, health inequalities, responsiveness, level and intensity of care and frugality) and low scores for 3 attributes (ethical, legal, and social issues [ELSIs], inclusiveness and eco-responsibility). At the rating step, 88% of the innovations had a sufficient number of attributes documented (= 7/9), but the assessment was based on sources of moderate to high quality (mean score = 2 points) for 36% of the sample. While Almost all RIH features were present for 24% of the innovations (RIH mean score between 4.1-5.0 points), Many RIH features were present for 52% of the sample (3.1-4.0 points) and Few RIH features were present for 24% of the innovations (2.1-3.0 points). Conclusion: By confirming key aspects of the RIH Tool's reliability and applicability, our study brings its development to completion. It can be jointly put into action by innovation stakeholders who want to foster innovations with greater social, economic and environmental value. Copyright: (c) 2021 The Author(s); Published by Kerman University of Medical Sciences.

Automated summary

The study developed and validated an evidence-informed assessment tool for assessing health innovations against Responsible Innovation in Health (RIH) requirements, showing high agreement in screening criteria and assessment attributes.